Week 8 Final Exam: NR546 / NR-546 (Latest 2025 / 2026) Advanced Pharmacology Psychopharmacology for the PMHNP | Questions and Answers | 100% Correct | Grade A - Chamberlain

Week 8 Final Exam: NR546 / NR-546
(Latest ) Advanced
Pharmacology Psychopharmacology
for the PMHNP | Questions and
Answers | 100% Correct | Grade A -
Chamberlain


Question:
How do you prescribe the appropriate pharmacological treatment for AD
Answer:
Pharmacologic treatment choices focus on helping the client manage
symptoms and behavioral issues that may present.




Question:
Common s/e of acetylcholinesterase inhibitors (cHels)
Answer:
GI Symptoms
dizziness
weakness
headache

,Question:
Formulations for rivastigmine (exelon)
Answer:
orally ad transdermal patch




Question:
when is the exolon patch indicated
Answer:
dementia associated with Parkinson's disease.




Question:
MOA of galantamine
Answer:
acts by elevating acetylcholine (Ach) in the cerebral cortex, modulating the
nicotinic Ach receptors to increase Ach release from existing presynaptic
nerve terminals. It also increases glutamate and serotonin levels




Question:
Which ATD med has the most s/e
Answer:
donepezil

, Question:
s/e of galantamine
Answer:
typical ChEIs symptoms and fatigue




Question:
Precautions for exelon
Answer:
asthma or chronic obstructive pulmonary disorder (COPD)
sick sinus syndrome
gastrointestinal (GI) Bleeding
weight < 50 kg




Question:
Contraindications for galantamine
Answer:
severe hepatic impairment
severe renal impairment